 digoxin immun fab therapi manag digitali intox safeti efficaci result observ surveil studi observ surveil studi safeti effect treatment digoxin immun fab ovin digibind patient digitali intox april limit number patient treatment digoxin-specif fab fragment multicent clinic trial commerci avail juli studi addit clinic data treatment week follow-up studi adult digoxin immun fab ovin patient equal year old develop toxic mainten digoxin fifti percent patient complet respons treatment partial respons respons respons patient uncertain patient confid interv allerg reaction digoxin-specif antibodi fragment histori allergi antibiot drug patient confid interv recrudesc toxic risk recrudesc toxic dose antibodi total patient experienc posttreat advers event event patient manifest underli diseas unrel fab treatment digoxin-specif antibodi fragment effect patient physician life-threaten digitali intox